Karim Mahawish: Ischaemic Stroke Despite Anticoagulation in Atrial Fibrillation
Karim Mahawish, Senior Medical Officer in Geriatric, General and Stroke Medicine at Counties Manukau Health, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published NZMJ, in adding:
” ‘ Breakthrough stroke’ is often not true anticoagulant failure.
Pleased to share our new publication in the New Zealand Medical Journal examining ischaemic stroke/TIA occurring despite oral anticoagulation in patients with atrial fibrillation.
In a real-world Auckland cohort of 179 anticoagulated patients with AF who presented with IS/TIA, most events were not simply ‘drug failure’:
77percent were adjudicated as cardioembolic, but many were associated with anticoagulant under-exposure, including missed doses, under-dosing, or low laboratory markers of anticoagulant effect.
Conversely, patients with good anticoagulant control were more likely to have a non-cardioembolic mechanism, with good control independently associated with non-cardioembolic IS/TIA in adjusted analysis.
The clinical message is simple but important: when stroke occurs despite anticoagulation, we should not reflexively escalate antithrombotic therapy. We need careful aetiological assessment, review of adherence and dosing, and targeted secondary prevention.
As anticoagulant uptake improves, the prevention challenge increasingly shifts from ‘was anticoagulation prescribed?’ to ‘was anticoagulation effectively delivered?’
Grateful to my co-authors Valery Feigin, Rita Krishnamurthi and Harvey White, and to the ARCOS team.”
Title: Mechanisms of ischaemic strokes and transient ischaemic attacks despite oral anticoagulation in patients with atrial fibrillation
Authors: Mahawish KM, Feigin V, Krishnamurthi R, White HD. Mechanism
Stay updated with Hemostasis Today.
-
Jun 11, 2026, 16:46Moaz Abouelmagd: Key Findings from a Large Network Meta-Analysis of IV Thrombolytics in Acute Ischemic Stroke
-
Jun 11, 2026, 16:37Wolfgang Miesbach: From Failed Intravitreal Trials to Real Benefit – Subretinal AAV8 Gene Therapy in Pediatric X-Linked Retinoschisis
-
Jun 11, 2026, 16:34Joao Mariano Pego: Advancing Coagulation Diagnostics Through Standardized Thrombin Generation
-
Jun 11, 2026, 16:33Ifeanyichukwu Ifechidere: Nobody Talks About Thrombosis in Sickle Cell Disease
-
Jun 11, 2026, 16:29Salim Virani: The 2026 ACC/AHA Multisociety Dyslipidemia Guideline Promotes Early Prevention
-
Jun 11, 2026, 16:25Toyosi Onwuemene: What Clinicians Reveal About Bleeding and Clotting Care
-
Jun 11, 2026, 16:20Tejas Ahire: Rh Incompatibility – A Small Blood Group Difference with Big Clinical Impact
-
Jun 11, 2026, 16:19Jack Shuang Hou: Bayer Advances Asundexian as EMA Reviews New Option for Preventing Recurrent Ischemic Stroke
-
Jun 11, 2026, 15:50Shatri Albertina: New Publication on DVT Among Surgical Patients Receiving Thromboprophylaxis